Luísa Menezes-Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Luísa Menezes-Silva has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Niels Olsen Saraiva Câmara
Federal University of São Paulo
4 shared publications - Carlo José Freire Oliveira
Department of Microbiology, Immunology and Parasitology, Institute of Biological and Natural Sciences, Federal University of Triângulo Mineiro, Uberaba, Brazil
2 shared publications - Cristiane Bitencourt Dias
Universidade de São Paulo, Brazil
2 shared publications - Eloisa Martins da Silva
Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
2 shared publications - Lecticia Barbosa Jorge
Department of Nephrology, Faculty of Medicine, University of São Paulo, São Paulo 00458-020, Brazil
2 shared publications - Luis Yu
Universidade de São Paulo, Brazil
2 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by Elsevier in SSRN Electronic Journal
HIF-1α Restrains Oxidative Metabolism and Suppressive Function in RORγt⁺ Regulatory T Cells
Regulatory T cells (Tregs) expressing RORγt accumulate in the intestinal mucosa, but the signals that determine whether these cells remain suppressive or acquire inflammatory features are incompletely defined. Here, we identified Crohn’s disease (CD)-enriched FOXP3⁺ T-cell states in human ileal single-cell data that converged on RORC, HIF1A, hypoxia-responsive, inflammatory, and metabolic programs. Genetic deletion of HIF1A (ΔHIF1A) in RORγt-expressing cells protected mice from acute DSS colitis, T-cell transfer colitis, and azoxymethane/DSS-induced colitis-associated colorectal cancer (CAC). In Rag1-/- recipients given the same pathogenic naïve T cells, cotransfer of ΔHIF1A Tregs provided greater protection than cotransfer of WT Tregs, directly linking the phenotype to regulatory-cell function in vivo. Reanalysis of mouse colonic Treg scATAC-seq showed that RORγt⁺ Tregs with low HIF1A motif-associated accessibility preferentially engaged an oxidative, mitochondrial-fitness program characterized by greater Cpt1a, Opa1, and Mfn2 activity, whereas the motif-high state favored stress- and glycolysis-associated accessibility. Consistently, ΔHIF1A RORγt⁺ Tregs produced more IL-10 and less IL-17A and IFN-γ, more strongly limited responder-cell proliferation in vitro, contained fewer dysfunctional and mitochondrial-reactive-oxygen-species-high cells, favored fusion-associated transcription, and displayed greater basal and maximal oxygen consumption and reserve capacity, a profile lost after oxidative metabolism blockage with Oligomycin. In human CD, trajectory and gene-regulatory-network analyses further predicted that HIF1A perturbation would oppose selected disease-associated branches. Together, these data identify HIF-1α as a metabolic checkpoint connecting hypoxia-responsive transcription to mitochondrial fitness and inflammatory plasticity in intestinal RORγt⁺ Tregs.
- 3 November 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessHIF-1α Restrains Oxidative Metabolism and Suppressive Function in RORγt⁺ Regulatory T Cells
Regulatory T cells (Tregs) expressing RORγt accumulate in the intestinal mucosa, but the signals that determine whether these cells remain suppressive or acquire inflammatory features are incompletely defined. Here, we identified Crohn’s disease (CD)-enriched FOXP3⁺ T-cell states in human ileal single-cell data that converged on RORC, HIF1A, hypoxia-responsive, inflammatory, and metabolic programs. Genetic deletion of HIF1A (ΔHIF1A) in RORγt-expressing cells protected mice from acute DSS colitis, T-cell transfer colitis, and azoxymethane/DSS-induced colitis-associated colorectal cancer (CAC). In Rag1-/- recipients given the same pathogenic naïve T cells, cotransfer of ΔHIF1A Tregs provided greater protection than cotransfer of WT Tregs, directly linking the phenotype to regulatory-cell function in vivo. Reanalysis of mouse colonic Treg scATAC-seq showed that RORγt⁺ Tregs with low HIF1A motif-associated accessibility preferentially engaged an oxidative, mitochondrial-fitness program characterized by greater Cpt1a, Opa1, and Mfn2 activity, whereas the motif-high state favored stress- and glycolysis-associated accessibility. Consistently, ΔHIF1A RORγt⁺ Tregs produced more IL-10 and less IL-17A and IFN-γ, more strongly limited responder-cell proliferation in vitro, contained fewer dysfunctional and mitochondrial-reactive-oxygen-species-high cells, favored fusion-associated transcription, and displayed greater basal and maximal oxygen consumption and reserve capacity, a profile lost after oxidative metabolism blockage with Oligomycin. In human CD, trajectory and gene-regulatory-network analyses further predicted that HIF1A perturbation would oppose selected disease-associated branches. Together, these data identify HIF-1α as a metabolic checkpoint connecting hypoxia-responsive transcription to mitochondrial fitness and inflammatory plasticity in intestinal RORγt⁺ Tregs.
- Open Access
- 28 October 2026
- Published by Springer Nature in Current Tissue Microenvironment Reports
- Vol. 7 (1) , 9
Connecting Host–parasite Interactions to the Microbiota–gut–brain Axis
Purpose of Review: To provide a comprehensive overview of the key findings on the microbiota–gut–brain axis. Recent Findings: Growing evidence indicates that microbial metabolites, neurotransmitters, cytokines, and gut-derived hormones modulate blood–brain barrier integrity, neuroinflammation, and brain function, while the brain reciprocally shapes gut physiology through neuroendocrine and autonomic pathways. Disruption of this axis by dysbiosis has been implicated in a broad spectrum of disorders, including depression, schizophrenia, neurodevelopmental diseases, and chronic inflammatory conditions. More recently, infectious diseases have emerged as important modulators of the microbiota–gut–brain axis, as pathogens such as Toxoplasma gondii , Plasmodium spp ., Trypanosoma cruzi , and Leishmania spp . induce microbial dysbiosis, intestinal barrier dysfunction, and systemic immune activation that may contribute to neuroinflammation and neurological manifestations. Summary: The microbiota-gut-brain axis represents an interorgan communication system that integrates immune, neural, metabolic, and endocrine signals between the gastrointestinal tract and the central nervous system. The gut microbiota, composed of a vast diversity of microorganisms, plays a fundamental role in maintaining host homeostasis and immunity. Evidence indicates that alterations in its composition, such as dysbiosis, can compromise the integrity of the intestinal and the blood-brain barriers, favoring systemic inflammatory and neuroinflammatory processes associated with neurological, psychiatric disorders and infectious diseases. Furthermore, it dictates not only how the gut influences the brain in a steady state or during disease, but also how the brain coordinates the efferent signals to the gut. In this review, we elucidate the role of the microbiota-gut-brain axis in health and host disease and convey recent data showing that an imbalance in microbiota and gut infections could be mediating late effects on the central nervous system, through their direct effects on the gut barrier and immune system.
- 28 October 2026
- Published by Springer Nature in Current Tissue Microenvironment Reports
- Vol. 7 (1) , 9
Open AccessConnecting Host–parasite Interactions to the Microbiota–gut–brain Axis
Purpose of Review: To provide a comprehensive overview of the key findings on the microbiota–gut–brain axis. Recent Findings: Growing evidence indicates that microbial metabolites, neurotransmitters, cytokines, and gut-derived hormones modulate blood–brain barrier integrity, neuroinflammation, and brain function, while the brain reciprocally shapes gut physiology through neuroendocrine and autonomic pathways. Disruption of this axis by dysbiosis has been implicated in a broad spectrum of disorders, including depression, schizophrenia, neurodevelopmental diseases, and chronic inflammatory conditions. More recently, infectious diseases have emerged as important modulators of the microbiota–gut–brain axis, as pathogens such as Toxoplasma gondii , Plasmodium spp ., Trypanosoma cruzi , and Leishmania spp . induce microbial dysbiosis, intestinal barrier dysfunction, and systemic immune activation that may contribute to neuroinflammation and neurological manifestations. Summary: The microbiota-gut-brain axis represents an interorgan communication system that integrates immune, neural, metabolic, and endocrine signals between the gastrointestinal tract and the central nervous system. The gut microbiota, composed of a vast diversity of microorganisms, plays a fundamental role in maintaining host homeostasis and immunity. Evidence indicates that alterations in its composition, such as dysbiosis, can compromise the integrity of the intestinal and the blood-brain barriers, favoring systemic inflammatory and neuroinflammatory processes associated with neurological, psychiatric disorders and infectious diseases. Furthermore, it dictates not only how the gut influences the brain in a steady state or during disease, but also how the brain coordinates the efferent signals to the gut. In this review, we elucidate the role of the microbiota-gut-brain axis in health and host disease and convey recent data showing that an imbalance in microbiota and gut infections could be mediating late effects on the central nervous system, through their direct effects on the gut barrier and immune system.
- Open Access
- 1 February 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (3) , 437
JAK3 Staining and CD68+ Macrophage Counts Are Increased in Patients with IgA Nephropathy
Background/Objectives: IgA nephropathy (IgAN) is the most common primary glomerulopathy worldwide; it is characterized by a complex pathophysiology involving several inflammatory pathways. The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway may be critical in this process. This study aimed to investigate the role of this pathway in IgAN and examine related tissue inflammatory markers. Methods: We analyzed 63 biopsy-confirmed patients with IgAN and performed immunohistochemical analysis on renal samples. A panel of antibodies targeting the JAK/STAT pathway, including JAK2, JAK3, p-STAT, STAT3, and MAPK/ERK, was used for this analysis. Six kidney tumor border samples were used as controls. Additionally, CD68 staining was used to evaluate tissue inflammation in the kidney biopsies. Results: Patients with IgAN showed a significantly higher cellular density of JAK3 staining at the glomerular level compared to controls, indicating JAK3 activation (p < 0.0002). Nevertheless, the correlation between JAK3 positivity in glomeruli and clinical parameters such as the initial and final estimated glomerular filtration rate (eGFR) and proteinuria was not statistically significant. Identical results were obtained with CD68+ macrophage counts in the glomerular compartment, which did not show any correlation with clinical parameters, while CD68+ tubulointerstitial staining demonstrated a significant correlation with both initial (p = 0.002) and final eGFRs (p = 0.0014), proteinuria (p = 0.010), and interstitial fibrosis (p < 0.001), as well as with renal disease progression (p = 0.005). Conclusions: Activation of the JAK/STAT pathway was observed in patients with IgAN relative to controls, notwithstanding the inability to assess the full pathway due to technical limitations. Macrophage CD68 staining in the tubulointerstitial area increased and was associated with clinical and laboratory parameters such as eGFR and proteinuria. Additionally, MEST-C histological parameters, such as segmental glomerulosclerosis (S0/S1), tubular atrophy/interstitial fibrosis (T0/T1/T2), and crescents (C0/C1/C2), were associated with a higher number of CD68+ cells.
- 1 February 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (3) , 437
Open AccessJAK3 Staining and CD68+ Macrophage Counts Are Increased in Patients with IgA Nephropathy
Background/Objectives: IgA nephropathy (IgAN) is the most common primary glomerulopathy worldwide; it is characterized by a complex pathophysiology involving several inflammatory pathways. The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway may be critical in this process. This study aimed to investigate the role of this pathway in IgAN and examine related tissue inflammatory markers. Methods: We analyzed 63 biopsy-confirmed patients with IgAN and performed immunohistochemical analysis on renal samples. A panel of antibodies targeting the JAK/STAT pathway, including JAK2, JAK3, p-STAT, STAT3, and MAPK/ERK, was used for this analysis. Six kidney tumor border samples were used as controls. Additionally, CD68 staining was used to evaluate tissue inflammation in the kidney biopsies. Results: Patients with IgAN showed a significantly higher cellular density of JAK3 staining at the glomerular level compared to controls, indicating JAK3 activation (p < 0.0002). Nevertheless, the correlation between JAK3 positivity in glomeruli and clinical parameters such as the initial and final estimated glomerular filtration rate (eGFR) and proteinuria was not statistically significant. Identical results were obtained with CD68+ macrophage counts in the glomerular compartment, which did not show any correlation with clinical parameters, while CD68+ tubulointerstitial staining demonstrated a significant correlation with both initial (p = 0.002) and final eGFRs (p = 0.0014), proteinuria (p = 0.010), and interstitial fibrosis (p < 0.001), as well as with renal disease progression (p = 0.005). Conclusions: Activation of the JAK/STAT pathway was observed in patients with IgAN relative to controls, notwithstanding the inability to assess the full pathway due to technical limitations. Macrophage CD68 staining in the tubulointerstitial area increased and was associated with clinical and laboratory parameters such as eGFR and proteinuria. Additionally, MEST-C histological parameters, such as segmental glomerulosclerosis (S0/S1), tubular atrophy/interstitial fibrosis (T0/T1/T2), and crescents (C0/C1/C2), were associated with a higher number of CD68+ cells.
- Open Access
- 1 January 2026
- Published by MDPI AG in Preprints.org
JAK3 Staining and CD68+ Macrophage Counts are Increased in Patients with IgA Nephropathy
Background/Objectives: IgA nephropathy (IgAN) is the most common primary glomerulopathy worldwide; it is characterized by a complex pathophysiology involving several inflammatory pathways. The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway may be critical in this process. This study aimed to investigate the role of this pathway in IgAN and examine related tissue inflammatory markers. Methods: We analyzed 63 biopsy-confirmed patients with IgAN and performed immunohistochemical analysis on renal samples. A panel of antibodies targeting the JAK/STAT pathway, including JAK2, JAK3, p-STAT, STAT3, and MAPK/ERK, was used for this analysis. Six kidney tumor border samples were used as controls. Additionally, CD68 staining was used to evaluate tissue inflammation in the kidney biopsies. Results: Patients with IgAN showed a significantly higher cellular density of JAK3 staining at the glomerular level compared to controls, indicating JAK3 activation (p < 0.0002). Nevertheless, the correlation between JAK3 positivity in glomeruli and clinical parameters such as the initial and final estimated glomerular filtration rate (eGFR) and proteinuria was not statistically significant. Identical results were obtained with CD68+ macrophage counts in the glomerular compartment, which did not show any correlation with clinical parameters, while CD68+ tubulointerstitial staining demonstrated a significant correlation with both initial (p = 0.002) and final eGFRs (p = 0.0014), proteinuria (p = 0.010), and interstitial fibrosis (p < 0.001), as well as with renal disease progression (p = 0.005). Conclusions: Patients with IgAN exhibited activation of the JAK/STAT pathway, in contrast to controls. Macrophage CD68 staining in the tubulointerstitial area increased and was associated with clinical and laboratory parameters such as eGFR and proteinuria. Additionally, MEST-C histological parameters, such as segmental glomerulosclerosis (S0/S1), tubular atrophy/interstitial fibrosis (T0/T1/T2), and crescents (C0/C1/C2), were associated with a higher number of CD68+ cells.
- 1 January 2026
- Published by MDPI AG in Preprints.org
Open AccessJAK3 Staining and CD68+ Macrophage Counts are Increased in Patients with IgA Nephropathy
Background/Objectives: IgA nephropathy (IgAN) is the most common primary glomerulopathy worldwide; it is characterized by a complex pathophysiology involving several inflammatory pathways. The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway may be critical in this process. This study aimed to investigate the role of this pathway in IgAN and examine related tissue inflammatory markers. Methods: We analyzed 63 biopsy-confirmed patients with IgAN and performed immunohistochemical analysis on renal samples. A panel of antibodies targeting the JAK/STAT pathway, including JAK2, JAK3, p-STAT, STAT3, and MAPK/ERK, was used for this analysis. Six kidney tumor border samples were used as controls. Additionally, CD68 staining was used to evaluate tissue inflammation in the kidney biopsies. Results: Patients with IgAN showed a significantly higher cellular density of JAK3 staining at the glomerular level compared to controls, indicating JAK3 activation (p < 0.0002). Nevertheless, the correlation between JAK3 positivity in glomeruli and clinical parameters such as the initial and final estimated glomerular filtration rate (eGFR) and proteinuria was not statistically significant. Identical results were obtained with CD68+ macrophage counts in the glomerular compartment, which did not show any correlation with clinical parameters, while CD68+ tubulointerstitial staining demonstrated a significant correlation with both initial (p = 0.002) and final eGFRs (p = 0.0014), proteinuria (p = 0.010), and interstitial fibrosis (p < 0.001), as well as with renal disease progression (p = 0.005). Conclusions: Patients with IgAN exhibited activation of the JAK/STAT pathway, in contrast to controls. Macrophage CD68 staining in the tubulointerstitial area increased and was associated with clinical and laboratory parameters such as eGFR and proteinuria. Additionally, MEST-C histological parameters, such as segmental glomerulosclerosis (S0/S1), tubular atrophy/interstitial fibrosis (T0/T1/T2), and crescents (C0/C1/C2), were associated with a higher number of CD68+ cells.
- Open Access
- 18 October 2024
- Published by Springer Nature in Cell Death & Disease
- Vol. 15 (10) , 1-17
Sirtuin 1 regulates the phenotype and functions of dendritic cells through Ido1 pathway in obesity
Sirtuin 1 (SIRT1) is a class III histone deacetylase (HDAC3) that plays a crucial role in regulating the activation and differentiation of dendritic cells (DCs) as well as controlling the polarization and activation of T cells. Obesity, a chronic inflammatory condition, is characterized by the activation of immune cells in various tissues. We hypothesized that SIRT1 might influence the phenotype and functions of DCs through the Ido1 pathway, ultimately leading to the polarization towards pro-inflammatory T cells in obesity. In our study, we observed that SIRT1 activity was reduced in bone marrow-derived DCs (BMDCs) from obese animals. These BMDCs exhibited elevated oxidative phosphorylation (OXPHOS) and increased extracellular acidification rates (ECAR), along with enhanced expression of class II MHC, CD86, and CD40, and elevated secretion of IL-12p40, while the production of TGF-β was reduced. The kynurenine pathway activity was decreased in BMDCs from obese animals, particularly under SIRT1 inhibition. SIRT1 positively regulated the expression of Ido1 in DCs in a PPARγ-dependent manner. To support these findings, ATAC-seq analysis revealed that BMDCs from obese mice had differentially regulated open chromatin regions compared to those from lean mice, with reduced chromatin accessibility at the Sirt1 genomic locus in BMDCs from obese WT mice. Gene Ontology (GO) enrichment analysis indicated that BMDCs from obese animals had disrupted metabolic pathways, including those related to GTPase activity and insulin response. Differential expression analysis showed reduced levels of Pparg and Sirt1 in BMDCs from obese mice, which was challenged and confirmed using BMDCs from mice with conditional knockout of Sirt1 in dendritic cells (SIRT1∆). This study highlights that SIRT1 controls the metabolism and functions of DCs through modulation of the kynurenine pathway, with significant implications for obesity-related inflammation.
- 18 October 2024
- Published by Springer Nature in Cell Death & Disease
- Vol. 15 (10) , 1-17
Open AccessSirtuin 1 regulates the phenotype and functions of dendritic cells through Ido1 pathway in obesity
Sirtuin 1 (SIRT1) is a class III histone deacetylase (HDAC3) that plays a crucial role in regulating the activation and differentiation of dendritic cells (DCs) as well as controlling the polarization and activation of T cells. Obesity, a chronic inflammatory condition, is characterized by the activation of immune cells in various tissues. We hypothesized that SIRT1 might influence the phenotype and functions of DCs through the Ido1 pathway, ultimately leading to the polarization towards pro-inflammatory T cells in obesity. In our study, we observed that SIRT1 activity was reduced in bone marrow-derived DCs (BMDCs) from obese animals. These BMDCs exhibited elevated oxidative phosphorylation (OXPHOS) and increased extracellular acidification rates (ECAR), along with enhanced expression of class II MHC, CD86, and CD40, and elevated secretion of IL-12p40, while the production of TGF-β was reduced. The kynurenine pathway activity was decreased in BMDCs from obese animals, particularly under SIRT1 inhibition. SIRT1 positively regulated the expression of Ido1 in DCs in a PPARγ-dependent manner. To support these findings, ATAC-seq analysis revealed that BMDCs from obese mice had differentially regulated open chromatin regions compared to those from lean mice, with reduced chromatin accessibility at the Sirt1 genomic locus in BMDCs from obese WT mice. Gene Ontology (GO) enrichment analysis indicated that BMDCs from obese animals had disrupted metabolic pathways, including those related to GTPase activity and insulin response. Differential expression analysis showed reduced levels of Pparg and Sirt1 in BMDCs from obese mice, which was challenged and confirmed using BMDCs from mice with conditional knockout of Sirt1 in dendritic cells (SIRT1∆). This study highlights that SIRT1 controls the metabolism and functions of DCs through modulation of the kynurenine pathway, with significant implications for obesity-related inflammation.
- Open Access
- 17 February 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (4) , 2363
Cisplatin Toxicity Causes Neutrophil-Mediated Inflammation in Zebrafish Larvae
Cisplatin is an antineoplastic agent used to treat various tumors. In mammals, it can cause nephrotoxicity, tissue damage, and inflammation. The release of inflammatory mediators leads to the recruitment and infiltration of immune cells, particularly neutrophils, at the site of inflammation. Cisplatin is often used as an inducer of acute kidney injury (AKI) in experimental models, including zebrafish (Danio rerio), due to its accumulation in kidney cells. Current protocols in larval zebrafish focus on studying its effect as an AKI inducer but ignore other systematic outcomes. In this study, cisplatin was added directly to the embryonic medium to assess its toxicity and impact on systemic inflammation using locomotor activity analysis, qPCR, microscopy, and flow cytometry. Our data showed that larvae exposed to cisplatin at 7 days post-fertilization (dpf) displayed dose-dependent mortality and morphological changes, leading to a decrease in locomotion speed at 9 dpf. The expression of pro-inflammatory cytokines such as interleukin (il)-12, il6, and il8 increased after 48 h of cisplatin exposure. Furthermore, while a decrease in the number of neutrophils was observed in the glomerular region of the pronephros, there was an increase in neutrophils throughout the entire animal after 48 h of cisplatin exposure. We demonstrate that cisplatin can have systemic effects in zebrafish larvae, including morphological and locomotory defects, increased inflammatory cytokines, and migration of neutrophils from the hematopoietic niche to other parts of the body. Therefore, this protocol can be used to induce systemic inflammation in zebrafish larvae for studying new therapies or mechanisms of action involving neutrophils.
- 17 February 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (4) , 2363
Open AccessCisplatin Toxicity Causes Neutrophil-Mediated Inflammation in Zebrafish Larvae
Cisplatin is an antineoplastic agent used to treat various tumors. In mammals, it can cause nephrotoxicity, tissue damage, and inflammation. The release of inflammatory mediators leads to the recruitment and infiltration of immune cells, particularly neutrophils, at the site of inflammation. Cisplatin is often used as an inducer of acute kidney injury (AKI) in experimental models, including zebrafish (Danio rerio), due to its accumulation in kidney cells. Current protocols in larval zebrafish focus on studying its effect as an AKI inducer but ignore other systematic outcomes. In this study, cisplatin was added directly to the embryonic medium to assess its toxicity and impact on systemic inflammation using locomotor activity analysis, qPCR, microscopy, and flow cytometry. Our data showed that larvae exposed to cisplatin at 7 days post-fertilization (dpf) displayed dose-dependent mortality and morphological changes, leading to a decrease in locomotion speed at 9 dpf. The expression of pro-inflammatory cytokines such as interleukin (il)-12, il6, and il8 increased after 48 h of cisplatin exposure. Furthermore, while a decrease in the number of neutrophils was observed in the glomerular region of the pronephros, there was an increase in neutrophils throughout the entire animal after 48 h of cisplatin exposure. We demonstrate that cisplatin can have systemic effects in zebrafish larvae, including morphological and locomotory defects, increased inflammatory cytokines, and migration of neutrophils from the hematopoietic niche to other parts of the body. Therefore, this protocol can be used to induce systemic inflammation in zebrafish larvae for studying new therapies or mechanisms of action involving neutrophils.
- Open Access
- 1 August 2019
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 106 (3) , 501-503
Connecting the dots in type 1 diabetes: The role for gut–pancreas axis
Discussion on changes in gut microbiota driving the breakdown of mucosal barrier in NOD mice; the resulting inflammation and impairment of oral tolerance induces the autoimmune diabetes.
- 1 August 2019
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 106 (3) , 501-503
Open AccessConnecting the dots in type 1 diabetes: The role for gut–pancreas axis
Discussion on changes in gut microbiota driving the breakdown of mucosal barrier in NOD mice; the resulting inflammation and impairment of oral tolerance induces the autoimmune diabetes.
- Open Access
- 22 July 2018
- Published by Wiley in Mediators of Inflammation
- Vol. 2018, 1-9
Salivary Gland Extract of Kissing Bug, Triatoma lecticularia, Reduces the Severity of Intestinal Inflammation through the Modulation of the Local IL-6/IL-10 Axis
Triatomines are known for their role as vectors of the causative agent of Chagas disease. The occurrence of an arsenal of molecules in their saliva is able to suppress vertebrate immune responses. Thus, it is reasonable to assume that the presence of molecules with therapeutic potential in their saliva is able to constrain inflammation in immune-mediated diseases. Thus, mice were exposed to dextran sulfate sodium (DSS) in drinking water uninterruptedly during 6 consecutive days and treated with T. lecticularia salivary gland extract (SGE) (3, 10, or 30 μg) or vehicle (saline) (/group). At the highest dose (30 μg), an improvement in clinical outcome and macroscopic aspects of the intestine were observed. This observation was followed by amelioration in histopathological aspects in the colon especially when the doses of 10 and 30 μg were used. Regardless of the concentration used, treatment with T. lecticularia SGE significantly reduced the levels of the inflammatory cytokine IL-6 in the intestine. The production of the anti-inflammatory cytokine IL-10 was positively impacted by the concentrations of 3 and 30 μg. Our results suggest that the presence of molecules in the T. lecticularia SGE is able to attenuate clinical outcome and colon shortening and improve intestinal architecture besides reducing the production of IL-6 and inducing a local production of IL-10 in the intestine.- 22 July 2018
- Published by Wiley in Mediators of Inflammation
- Vol. 2018, 1-9
Open AccessSalivary Gland Extract of Kissing Bug, Triatoma lecticularia, Reduces the Severity of Intestinal Inflammation through the Modulation of the Local IL-6/IL-10 Axis
Triatomines are known for their role as vectors of the causative agent of Chagas disease. The occurrence of an arsenal of molecules in their saliva is able to suppress vertebrate immune responses. Thus, it is reasonable to assume that the presence of molecules with therapeutic potential in their saliva is able to constrain inflammation in immune-mediated diseases. Thus, mice were exposed to dextran sulfate sodium (DSS) in drinking water uninterruptedly during 6 consecutive days and treated with T. lecticularia salivary gland extract (SGE) (3, 10, or 30 μg) or vehicle (saline) (/group). At the highest dose (30 μg), an improvement in clinical outcome and macroscopic aspects of the intestine were observed. This observation was followed by amelioration in histopathological aspects in the colon especially when the doses of 10 and 30 μg were used. Regardless of the concentration used, treatment with T. lecticularia SGE significantly reduced the levels of the inflammatory cytokine IL-6 in the intestine. The production of the anti-inflammatory cytokine IL-10 was positively impacted by the concentrations of 3 and 30 μg. Our results suggest that the presence of molecules in the T. lecticularia SGE is able to attenuate clinical outcome and colon shortening and improve intestinal architecture besides reducing the production of IL-6 and inducing a local production of IL-10 in the intestine.